A detailed history of Mcdonald Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mcdonald Partners LLC holds 22,078 shares of ABBV stock, worth $3.97 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
22,078
Previous 24,470 9.78%
Holding current value
$3.97 Million
Previous $4.2 Million 3.86%
% of portfolio
1.12%
Previous 1.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $391,905 - $476,797
-2,392 Reduced 9.78%
22,078 $4.36 Million
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $169,185 - $197,570
1,093 Added 4.68%
24,470 $4.2 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $143,518 - $163,525
898 Added 3.99%
23,377 $4.26 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $13,209 - $14,877
96 Added 0.43%
22,479 $3.48 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $426,419 - $493,642
3,192 Added 16.63%
22,383 $3.34 Million
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $230,169 - $286,431
1,737 Added 9.95%
19,191 $2.59 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $99,925 - $115,079
691 Added 4.12%
17,454 $2.78 Million
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $89,763 - $107,649
-649 Reduced 3.73%
16,763 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $101,596 - $116,525
-757 Reduced 4.17%
17,412 $2.34 Million
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $52,433 - $66,659
-381 Reduced 2.05%
18,169 $2.78 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $2.44 Million - $3.03 Million
18,494 Added 33025.0%
18,550 $3.01 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $1.79 Million - $2.26 Million
-16,626 Reduced 99.66%
56 $7,000
Q3 2021

Nov 24, 2021

SELL
$106.4 - $120.78 $118,423 - $134,428
-1,113 Reduced 6.25%
16,682 $1.8 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $167,580 - $190,228
1,575 Added 9.71%
17,795 $1.92 Million
Q2 2021

Nov 24, 2021

SELL
$105.21 - $117.21 $103,316 - $115,100
-982 Reduced 5.71%
16,220 $1.83 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $114,152 - $127,172
1,085 Added 6.73%
17,202 $1.94 Million
Q1 2021

Nov 24, 2021

SELL
$102.3 - $112.62 $243,678 - $268,260
-2,382 Reduced 12.88%
16,117 $1.74 Million
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $260,251 - $286,505
2,544 Added 15.94%
18,499 $2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.28 Million - $1.73 Million
15,955 New
15,955 $1.71 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mcdonald Partners LLC Portfolio

Follow Mcdonald Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.